Invention Grant
- Patent Title: CRISPR-associated (CAS) protein
-
Application No.: US17097880Application Date: 2020-11-13
-
Publication No.: US11293011B2Publication Date: 2022-04-05
- Inventor: Matthew Merrill Carter , Paul Daniel Donohoue
- Applicant: Locanabio, Inc.
- Applicant Address: US CA San Diego
- Assignee: Locanabio, Inc.
- Current Assignee: Locanabio, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Cooley LLP
- Agent Ivor R. Elrifi; Andrew Henderson
- Main IPC: C12N9/22
- IPC: C12N9/22 ; C12N15/11 ; C12N15/113 ; C12N15/85
Abstract:
A new CRISPR-associated (Cas) protein, termed “CasM,” is described, as well as polynucleotides encoding the same and methods of using CasM for site-specific genome engineering. CasM proteins are capable of targeting and cleaving single-stranded RNA.
Public/Granted literature
- US20210079367A1 NOVEL CRISPR-ASSOCIATED (CAS) PROTEIN Public/Granted day:2021-03-18
Information query
